New obesity drug enters first human tests
Disease control
Terminated
This early-stage study tests a new drug called HCR-188 in 48 overweight or obese adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo as injections. The goal is to gather initial safety data, not to treat obesity at this poi…
Phase: EARLY_PHASE1 • Sponsor: Helicore Biopharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC